View in EDS HTML Full Text PDF Full Text

Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.

Saved in:
Bibliographic Details
Title: Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.
Authors: Malmon S; Pixilib SAS, Toulouse, France., Elsensohn MH; Biostatistics Department, LYSARC, Lyon-Sud Hospital, Pierre-Bénite, France., Thieblemont C; APHP, Hôpital Saint-Louis, Hemato-Oncology, Paris, France.; Université Paris Cité, Paris, France., Morschhauser F; Department of Hematology, Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche Sur les Formes Injectables et les Technologies Associées, Lille, F-59000, France., Casasnovas O; Department of Hematology, CHU Dijon and INSERM UMR1231, Dijon, France., André M; Department of Hematology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium., Gouill SL; Service d'hématologie, Institut Curie, Saint Cloud, France.; Université de Versailles Saint-Quentin (UVSQ), Paris, France.; Laboratoire d'Imagerie Translationnelle en Oncologie (LITO), U1288 Inserm/Institut Curie Centre de Recherche, Paris, France., Tabaa YA; Scintidoc Nuclear Medicine Center, Clinique Clémentville, Montpellier, France., Durand PB; Department of Nuclear Medicine, CHU H. Mondor, U-PEC, AP-HP, Créteil, France., Bailly C; Nuclear Medicine Department, Nantes University Hospital, 1, Place Alexis Ricordeau, Nantes, 44000, France.; Nantes Université, Inserm, CNRS, Université d'Angers, CRCI2NA, 8 Quai Moncousu, BP70721, Cedex 1, Nantes, 44007, France., Edeline V; Department of Nuclear Medicine, Hôpital La Pitié Salpetrière, Paris, France., Vija L; Nuclear Medicine Department, Oncopole Claudius Regaud, Toulouse, France., Vercellino L; Nuclear Medicine Department, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.; INSERM UMR_S942, Université Paris Cité, Paris, 75006, France., Ricci R; LYSARC, Centre Hospitalier Lyon-Sud, 165 Chemin du Grand Revoyet Bâtiment 2D, Pierre-Bénite, 69310, France., Kanoun S; Centre de Recherche Clinique de Toulouse, Team 9, Toulouse, France., Cottereau AS; Nuclear Medicine Department, AP-HP, Hôpital Cochin, Paris, France. annesegolene.cottereau@aphp.fr.; Université Paris Cité, Paris, 75006, France. annesegolene.cottereau@aphp.fr.
Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2025 Jul; Vol. 52 (9), pp. 3180-3189. Date of Electronic Publication: 2025 Mar 20.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40108044
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Malmon+S%22">Malmon S</searchLink>; Pixilib SAS, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Elsensohn+MH%22">Elsensohn MH</searchLink>; Biostatistics Department, LYSARC, Lyon-Sud Hospital, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Thieblemont+C%22">Thieblemont C</searchLink>; APHP, Hôpital Saint-Louis, Hemato-Oncology, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Morschhauser+F%22">Morschhauser F</searchLink>; Department of Hematology, Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche Sur les Formes Injectables et les Technologies Associées, Lille, F-59000, France.<br /><searchLink fieldCode="AU" term="%22Casasnovas+O%22">Casasnovas O</searchLink>; Department of Hematology, CHU Dijon and INSERM UMR1231, Dijon, France.<br /><searchLink fieldCode="AU" term="%22André+M%22">André M</searchLink>; Department of Hematology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.<br /><searchLink fieldCode="AU" term="%22Gouill+SL%22">Gouill SL</searchLink>; Service d'hématologie, Institut Curie, Saint Cloud, France.; Université de Versailles Saint-Quentin (UVSQ), Paris, France.; Laboratoire d'Imagerie Translationnelle en Oncologie (LITO), U1288 Inserm/Institut Curie Centre de Recherche, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tabaa+YA%22">Tabaa YA</searchLink>; Scintidoc Nuclear Medicine Center, Clinique Clémentville, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Durand+PB%22">Durand PB</searchLink>; Department of Nuclear Medicine, CHU H. Mondor, U-PEC, AP-HP, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Bailly+C%22">Bailly C</searchLink>; Nuclear Medicine Department, Nantes University Hospital, 1, Place Alexis Ricordeau, Nantes, 44000, France.; Nantes Université, Inserm, CNRS, Université d'Angers, CRCI2NA, 8 Quai Moncousu, BP70721, Cedex 1, Nantes, 44007, France.<br /><searchLink fieldCode="AU" term="%22Edeline+V%22">Edeline V</searchLink>; Department of Nuclear Medicine, Hôpital La Pitié Salpetrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vija+L%22">Vija L</searchLink>; Nuclear Medicine Department, Oncopole Claudius Regaud, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Vercellino+L%22">Vercellino L</searchLink>; Nuclear Medicine Department, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.; INSERM UMR_S942, Université Paris Cité, Paris, 75006, France.<br /><searchLink fieldCode="AU" term="%22Ricci+R%22">Ricci R</searchLink>; LYSARC, Centre Hospitalier Lyon-Sud, 165 Chemin du Grand Revoyet Bâtiment 2D, Pierre-Bénite, 69310, France.<br /><searchLink fieldCode="AU" term="%22Kanoun+S%22">Kanoun S</searchLink>; Centre de Recherche Clinique de Toulouse, Team 9, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Cottereau+AS%22">Cottereau AS</searchLink>; Nuclear Medicine Department, AP-HP, Hôpital Cochin, Paris, France. annesegolene.cottereau@aphp.fr.; Université Paris Cité, Paris, 75006, France. annesegolene.cottereau@aphp.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2025 Jul; Vol. 52 (9), pp. 3180-3189. <i>Date of Electronic Publication: </i>2025 Mar 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40108044
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00259-025-07176-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3180
    Titles:
      – TitleFull: Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Malmon S
      – PersonEntity:
          Name:
            NameFull: Elsensohn MH
      – PersonEntity:
          Name:
            NameFull: Thieblemont C
      – PersonEntity:
          Name:
            NameFull: Morschhauser F
      – PersonEntity:
          Name:
            NameFull: Casasnovas O
      – PersonEntity:
          Name:
            NameFull: André M
      – PersonEntity:
          Name:
            NameFull: Gouill SL
      – PersonEntity:
          Name:
            NameFull: Tabaa YA
      – PersonEntity:
          Name:
            NameFull: Durand PB
      – PersonEntity:
          Name:
            NameFull: Bailly C
      – PersonEntity:
          Name:
            NameFull: Edeline V
      – PersonEntity:
          Name:
            NameFull: Vija L
      – PersonEntity:
          Name:
            NameFull: Vercellino L
      – PersonEntity:
          Name:
            NameFull: Ricci R
      – PersonEntity:
          Name:
            NameFull: Kanoun S
      – PersonEntity:
          Name:
            NameFull: Cottereau AS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1619-7089
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: European journal of nuclear medicine and molecular imaging
              Type: main
ResultId 1